Ping An Biomedical Co., Ltd.
For the period ended Oct 22, 2026. Filed Oct 22, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 22, 2026 · Filed Oct 22, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · PROPOSAL TWO
PROPOSAL TWO
TO RESOLVE as a special resolution, subject to approval by the shareholders of Proposal One, to ratify the adoption of the third amended and restated memorandum and articles of association of the Company in the form attached as Exhibit 99.3 (the “Third Amended and Restated M&A”) to reflect the Share Consolidation taking effect on the Effective Date, which was previously adopted by a unanimous written resolution of the Board passed on 6 August, 2026 as authorized by a special resolution passed at the previous annual general meeting held on 18 March, 2026 (the “Adoption of the Third Amended and Restated M&A”).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.